Annotation Detail for SSX2


Gene Symbol: | SSX2 ( CT5.2a,HD21,HOM-MEL-40,MGC119055,MGC15364,MGC3884,SSX,SSX2B ) |
---|---|
Gene Full Name: | synovial sarcoma, X breakpoint 2 |
Band: | Xp11.22 |
Quick Links | Entrez ID:6757; OMIM: 300192; Uniprot ID:SSX2_HUMAN; ENSEMBL ID: ENSG00000187754,ENSG00000241476; HGNC ID: 11336 |
Relate to Another Database: | SFARIGene; denovo-db |
Desease ID | Desease Name |
---|---|
Cancers | |
Cancers of soft tissues and bone | |
H00050 | Synovial sarcoma |
No data |
No data |
No data |
Desease Name |
---|
Sarcoma, synovial |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C014347 | decitabine | decitabine affects the expression of SSX2 mRNA | affects expression | 17145863 18240144 |
C014347 | decitabine | decitabine results in increased expression of SSX2 mRNA | increases expression | 19401350 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D001943 | Breast Neoplasms | decitabine | 2.52 | 19208741 18320071 | |
MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 2.70 | 19215824 | |
MESH:D003110 | Colonic Neoplasms | decitabine | 2.40 | 17616700 | |
MESH:D015179 | Colorectal Neoplasms | decitabine | 2.11 | 18981723 | |
MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 6.53 | 19294695 | |
MESH:D006258 | Head and Neck Neoplasms | decitabine | 3.83 | 19215824 | |
MESH:D007248 | Infertility, Male | decitabine | 3.54 | 17581917 | |
MESH:D007938 | Leukemia | decitabine | 3.29 | 18980019 19235587 | |
MESH:D007951 | Leukemia, Myeloid | decitabine | 4.63 | 18454857 17236224 19117987 | |
MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 2.44 | 17679729 18206229 18704418 19010910 18460780 19387464 | |
MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 6.88 | 18055864 | |
MESH:D008223 | Lymphoma | decitabine | 3.80 | 19470736 | |
MESH:D008545 | Melanoma | decitabine | 2.30 | 16505122 17785578 | |
MESH:D009101 | Multiple Myeloma | decitabine | 3.72 | 18172295 | |
MESH:D009190 | Myelodysplastic Syndromes | decitabine | 3.65 | 18608210 19157545 19010910 16882708 | |
MESH:D009369 | Neoplasms | decitabine | 2.92 | 19470736 17925555 19116145 | |
MESH:D010051 | Ovarian Neoplasms | decitabine | 2.77 | 19331143 19259094 | |
MESH:D010190 | Pancreatic Neoplasms | decitabine | 2.91 | 19294695 | |
MESH:D055728 | Primary Myelofibrosis | decitabine | 5.64 | 17616702 | |
MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 17929270 | ||
MESH:D012208 | Rhabdomyosarcoma | decitabine | 5.10 | 19155313 | |
MESH:D013584 | Sarcoma, Synovial | marker/mechanism | 9428816 | ||
MESH:D013274 | Stomach Neoplasms | decitabine | 2.11 | 19037991 | |
MESH:D013964 | Thyroid Neoplasms | decitabine | 3.75 | 17967635 | |
MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 2.88 | 19087683 17616700 | |
MESH:D014604 | Uveal Neoplasms | decitabine | 6.33 | 17785578 |
No data |